Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01) Download the PDF here. This post appeared first on investingnews.com 0 Related Posts S&P Global: Fragmented Climate and Energy Strategies Will Define 2026 January 16, 2026 African Discovery Group Announces Shareholder Approval of Butembo Merger Agreement January 16, 2026 American Eagle Continues to Expand South Zone near Surface Mineralization: Highlights Include 140 m of 0.74% Copper Eq. and 130 m of 0.62% Copper Eq. January 16, 2026
American Eagle Continues to Expand South Zone near Surface Mineralization: Highlights Include 140 m of 0.74% Copper Eq. and 130 m of 0.62% Copper Eq. January 16, 2026